The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 349:1780 October 30, 2003 Number 18
NextNext

Ovarian Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
(American Cancer Society Atlas of Clinical Oncology.) Edited by Robert F. Ozols. 246 pp., illustrated, with CD-ROM. Hamilton, Ont., Canada, BC Decker, 2003. $129. ISBN 1-55009-096-8.

Oncologists tend, by nature and occupation, to be optimists, whereas pathologists are more inclined to be pessimists; to put it another way, oncologists are romantics, whereas pathologists are realists. Thus, oncologists point out that in the past few decades substantial progress has been made in the treatment of ovarian cancer, but pathologists, including me, note that the survival rate among patients with this disease has remained unchanged for the past quarter of a century. Both, of course, are right: five-year survival rates are incrementally, albeit slowly, increasing, and our basic understanding of the disease is rapidly evolving, but the survival . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.